B
BFRI
Biofrontera Inc
0.9799
+0.0590+6.41%After Hours: 0.9600 -0.0199 -2.03%16:28 04/02 EDT
OPEN/PREV CLOSE0.8800/0.9209
TODAY RANGE0.8800-0.9914
VOL131.62K
MARKET CAP11.41M
52 WEEK RANGE0.5360-1.190
AVG VOL (3M)379.68K
% TURNOVER1.13%
TURNOVER--
P/E (TTM)-0.9460
% RANGE11.94%
EPS(TTM)-1.0358
P/E(FORWARD)-27.9971
P/B1.089
BVPS0.8997
DIVIDEND--
P/S0.2737
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.06M
SHARES OUTSTANDING11.65M
NEXT EARNINGS05/13-05/18
FREE FLOAT9.25M
LOT SIZE1
EX-DATE07/05/2023
News
Press Releases
Financial Reports
Profile
TipRanks·03/20 13:17
Roth MKM Reaffirms Their Buy Rating on Biofrontera (BFRI)
TipRanks·03/20 00:09
Biofrontera Earnings Call: Profits Rise, Risks Remain
Seeking Alpha·03/19 19:18
Biofrontera reports rise in Q4 revenue, turns profitable
Seeking Alpha·03/19 19:12
Biofrontera outlines 80%-85% gross margin target for 2026 following strategic asset acquisition
Dow Jones·03/19 13:26
*Biofrontera 4Q Net $5.64M >BFRI
Dow Jones·03/19 13:26
*Biofrontera 4Q Rev $17.1M >BFRI
Reuters·03/19 13:25
BRIEF-Biofrontera Q4 Revenue USD 17.1 Million
Benzinga·03/19 11:11
Earnings Scheduled For March 19, 2026
TipRanks·03/09 13:49
Biofrontera Reports Positive Phase 2b Acne Trial Results
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.